Henig Yair Steve
Chief Scientific Officer at HLF
- Sold, on record
- $2.8M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Oct 5, 2010
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- HLFHERBALIFE LTD.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale HLFUnusualOct 9, 2009 2009
Sold 10,000 shares at $35.40 ($354k)
Henig Yair Steve, Chief Scientific Officer
Sold 34% of holdings ($1M position)19,388 shares leftFiling
- 2 Form 4 sale HLFUnusualOct 20, 2009 +11 days
Sold 15,000 shares at $37.73 ($566k)
Henig Yair Steve, Chief Scientific Officer
Sold 43.6% of holdings ($1.3M position)19,388 shares leftFiling
- 3 Form 4 sale HLFUnusualDec 18, 2009 +59 days
Sold 7,349 shares at $41.50 ($305k)
Henig Yair Steve, Chief Scientific Officer
Sold 30.9% of holdings ($988k position)16,460 shares left0.7x usual sizeFiling
- 4 Form 4 sale HLFPlan not statedDec 31, 2009 +13 days
Sold 5,000 shares at $40.55 ($203k)
Henig Yair Steve, Chief Scientific Officer
Sold 23.3% of holdings ($870k position)16,460 shares left0.6x usual sizeFiling
- 5 Form 4 sale HLFUnusualJun 30, 2010 +181 days
Sold 14,558 shares at $47.36 ($690k)
Henig Yair Steve, Chief Scientific Officer
Sold 53.7% of holdings ($1.3M position)12,532 shares left2x usual sizeFiling
- 6 Form 4 sale HLFPlan not statedJul 8, 2010 +8 days
Sold 1,791 shares at $48.00 ($86k)
Henig Yair Steve, Chief Scientific Officer
Sold 14.3% of holdings ($602k position)10,741 shares left0.2x usual sizeFiling
- 7 Form 4 sale HLFUnusualSep 16, 2010 +70 days
Sold 5,045 shares at $58.67 ($296k)
Henig Yair Steve, Chief Scientific Officer
Sold 34% of holdings ($870k position)9,776 shares left0.7x usual sizeFiling
- 8 Form 4 sale HLFPlan not statedOct 5, 2010 +19 days
Sold 1,804 shares at $61.00 ($110k)
Henig Yair Steve, Chief Scientific Officer
Sold 15.6% of holdings ($706k position)9,776 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2010 | Oct 5, 2010 | HLF | Chief Scientific Officer | Form 4 sale | 1,804 | $110k | 15.6% | Plan not stated | SEC |
| Sep 16, 2010 | Sep 17, 2010 | HLF | Chief Scientific Officer | Form 4 sale | 5,045 | $296k | 34.0% | Unusual | SEC |
| Jul 8, 2010 | Jul 9, 2010 | HLF | Chief Scientific Officer | Form 4 sale | 1,791 | $86k | 14.3% | Plan not stated | SEC |
| Jun 30, 2010 | Jun 30, 2010 | HLF | Chief Scientific Officer | Form 4 sale | 14,558 | $690k | 53.7% | Unusual | SEC |
| Dec 31, 2009 | Jan 5, 2010 | HLF | Chief Scientific Officer | Form 4 sale | 5,000 | $203k | 23.3% | Plan not stated | SEC |
| Dec 18, 2009 | Dec 22, 2009 | HLF | Chief Scientific Officer | Form 4 sale | 7,349 | $305k | 30.9% | Unusual | SEC |
| Oct 20, 2009 | Oct 21, 2009 | HLF | Chief Scientific Officer | Form 4 sale | 15,000 | $566k | 43.6% | Unusual | SEC |
| Oct 9, 2009 | Oct 13, 2009 | HLF | Chief Scientific Officer | Form 4 sale | 10,000 | $354k | 34.0% | Unusual | SEC |
| Sep 21, 2009 | Sep 22, 2009 | HLF | Chief Scientific Officer | Form 4 sale | 5,300 | $174k | 21.5% | Plan not stated | SEC |